Literature DB >> 14441852

Clinical investigation of trifluoperazine (stelazine) in open psychiatric settings.

G J SARWER-FONER, E K KORANYI, J MACKAY, H GRAUER.   

Abstract

Entities:  

Keywords:  MENTAL DISORDERS/therapy; PHENOTHIAZINES/therapy

Mesh：

Substances：

Year:  1959        PMID： 14441852      PMCID： PMC1831131     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Depressive states and drugs; a study of the use of imipramine tofranil in open psychiatric settings.

Authors:  G J SARWER-FONER; H GRAUER; J MACKAY; E K KORANYI
Journal:  Med Serv J Can       Date:  1959-06

2.  [Occurrence and interpretation of psychomotor parkinsonism in megaphen or largactil prolonged therapy].

Authors:  H J HAASE
Journal:  Nervenarzt       Date:  1954-12-20       Impact factor: 1.214

3.  The psychodynamic basis of compensation: a contribution to the study of ego defences.

Authors:  G J SARWER-FONER; T E DANCY
Journal:  Can Psychiatr Assoc J       Date:  1959-04

4.  [New types of neurological complications caused by a new neuroleptic drug, prochlorperazine].

Authors:  J DELAY; P DENIKER; J FOURMENT; A GREEN; M ROPERT
Journal:  Ann Med Psychol (Paris)       Date:  1957-03       Impact factor: 0.380

5.  Psychoanalytic theories of activity-passivity conflicts and of the continuum of ego defenses; experimental verification, using reserpine and chlorpromazine.

Authors:  G J SARWER-FONER
Journal:  AMA Arch Neurol Psychiatry       Date:  1957-10

6.  [Hysterical states of medicinal origin].

Authors:  J DELAY; P DENIKER
Journal:  Can Psychiatr Assoc J       Date:  1958-07

7.  The transference and nonspecific drug effects in the use of the tranquilizing drugs, and their influence on affect.

Authors:  G J SARWER-FONER
Journal:  Psychiatr Res Rep Am Psychiatr Assoc       Date:  1957-12

8.  [Excito-motor syndrome provoked by neuroleptic drugs].

Authors:  J DELAY; P DENIKER; A GREEN; M MORDRET
Journal:  Presse Med       Date:  1957-11-02       Impact factor: 1.228

9.  Psychosis and enhanced anxiety produced by reserpine and chlorpromazine.

Authors:  G J SARWER-FONER; W OGLE
Journal:  Can Med Assoc J       Date:  1956-04-01       Impact factor: 8.262

10.  The use of reserpine in an open psychiatric setting.

Authors:  G J SARWER-FONER; W OGLE
Journal:  Can Med Assoc J       Date:  1955-08-01       Impact factor: 8.262
  10 in total
  1 in total

1.  Recognition and management of drug-induced extra-pyramidal reactions and "paradoxical" behavioural reactions in psychiatry.

Authors:  G J SARWER-FONER
Journal:  Can Med Assoc J       Date:  1960-08-13       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.